Pierre Vidal possesses extensive experience in technology and innovation within the healthcare sector. Currently employed at CEA since November 2019 as a specialist in developing industrial technological partnerships, Pierre Vidal has played a pivotal role in bridging scientific advancements and industry needs. Previous roles include Chief Business Officer at Cerba Research and Co-Founder and CEO of Diag2TEC, a preclinical CRO focusing on hematological cancers. Pierre Vidal has also worked as a consultant and project manager across various organizations, contributing expertise in R&D, marketing, and strategy. Academic qualifications include a PhD in Biochemistry from the University of Montpellier and a Master's in Biophysics from Pierre and Marie Curie University, complemented by additional studies in company management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices